Itamochi Hiroaki 板持広明

… Alternative Names

ITAMOCHI Hiroaki 板持広明

Less

Researcher Number	20314601
Other IDs
Affiliation (Current)	2025: 岩手医科大学, 医学部, 教授
Affiliation (based on the past Project Information) *help	2015 – 2023: 岩手医科大学, 医学部, 教授 2014: 鳥取大学, 医学部, 准教授 2009 – 2013: 鳥取大学, 医学部, 講師 2007 – 2008: Tottori University, Hospital, Associate Professor 2005 – 2006: 鳥取大学, 医学部附属病院, 助手 … More 2004: 国立大学法人鳥取大学, 医学部附属病院, 助手 2002: 鳥取大, 医学部附属病院, 助手 2002: Tottori Univ. Dept. Obstet. Gynecol., Research Associates, 医学部附属病院, 助手 2001: 鳥取大学, 医学部・付属病院, 助手 2000 – 2001: 鳥取大学, 医学部・附属病院, 助手 Less
Review Section/Research Field	Principal Investigator Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related / Obstetrics and gynecology Except Principal Investigator Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related / Obstetrics and gynecology
Keywords	Principal Investigator 卵巣癌 / 明細胞癌 / バイオマーカー / 卵巣明細胞癌 / シスプラチン / 卵巣明細胞腺癌 / HSP / NEFH / 治療標的 / KANK1 … More / 卵巣がん / Aurora kinase A / Chemoresponse / Gene therapy / Carcinoma / 薬剤反応性 / 遺伝子 / 癌 / FGFR2 / MRP / S-phase fraction / 薬剤耐性 … More Except Principal Investigator 卵巣癌 / ovarian cancer / gene therapy / 遺伝子治療 / アポトーシス / 腫瘍溶解性ウイルス / 腫瘍浸潤リンパ球 / 子宮癌肉腫 / ウイルス療法 / 腫瘍免疫 / 腫瘍溶解性ヘルペスウイルス / genetic diagnosis / 抗癌剤 / 遺伝子 / 個別化治療 / 上皮性卵巣癌 / 遺伝子診断 / lperitonitis carcinomatosa model / apoptosis / P53 gene / 癌性腹膜炎 / p53 / mTOR阻害剤 / PI3K阻害剤 / PIK3CA / 明細胞癌 / PI3K / 明細胞腺癌 / 疫学研究 / がん化 / 子宮内膜症 / JEMS Less

卵巣明細胞癌に対するＨＳＦ１経路を標的とした新規治療法の開発Principal Investigator
- Principal Investigator
  
  板持広明
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Iwate Medical University
子宮癌肉腫に対する免疫逃避改善を誘導するウイルス療法の開発
- Principal Investigator
  
  利部正裕
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Iwate Medical University
The NEFH pathway may be a novel therapeutic target for ovarian clear cell carcinomaPrincipal Investigator
- Principal Investigator
  
  ITAMOCHI Hiroaki
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Iwate Medical University
The KANK1 pathway may be a novel therapeutic target for ovarian clear cell carcinomaPrincipal Investigator
- Principal Investigator
  
  ITAMOCHI Hiroaki
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Iwate Medical University
Development of combination therapy using PI3K inhibitor and its predictive biomarker in clear cell carcinoma of the ovary
- Principal Investigator
  
  Oishi Tetsuro
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approachPrincipal Investigator
- Principal Investigator
  
  ITAMOCHI Hiroaki
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
Investigation into malignant transformation of endometriosis. prospective cohort study and molecular biology research
- Principal Investigator
  
  TERAKAWA Naoki
- Project Period (FY)
  2008 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (A)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
Adenovirus type 5 EIA gene therapy for ovarian carcinomaPrincipal Investigator
- Principal Investigator
  
  ITAMOCHI Hiroaki
- Project Period (FY)
  2005 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
Order made gene therapy for epithelial ovarian cancer on biological behavior
- Principal Investigator
  
  KIGAWA Junzou
- Project Period (FY)
  2004 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
卵巣明細胞腺癌の抗癌剤耐性機序とその克服Principal Investigator
- Principal Investigator
  
  板持広明
- Project Period (FY)
  2001 – 2002
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
Gene therapy enhances chemotherapy induced apoptosis in a peritonitis carcinomatosa model with ovarian cancer
- Principal Investigator
  
  KIGAWA Junzo
- Project Period (FY)
  2000 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University School of Medicine

All 2021 2018 2017 2015 2014 2013 2011 2010 2009 2008 2007 2006 2005 Other

All Journal Article Presentation Book

[Book] よくわかる卵巣癌のすべて2007
- Author(s)
  板持広明
- Publisher
  永井書店
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Book] All about ovarian carcinoma2007
- Author(s)
  Hiroaki, Itamochi
- Publisher
  Nagai Shoten
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Book] 新選産婦人科診療2006
- Author(s)
  板持広明
- Publisher
  永井書店
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Book] New Consensus of Obstetrics and Gynecology2006
- Author(s)
  Hiroaki, Itamochi
- Publisher
  Nagai Shoten
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Journal Article] Novel therapeutic strategies for refractory ovarian cancers: Clear cell and mucinous carcinomas.2021
- Author(s)
  Shoji T, Tatsuki S, Abe M, Tomabechi H, Takatori E, Kaido Y, Nagasawa T, Kagabu M, Baba T, Itamochi H.
- Journal Title
  
  Cancers
  
  Volume: 13 Issue: 23 Pages: 6120-6120
- DOI
  10.3390/cancers13236120
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09759
[Journal Article] Inhibition of Aurora Kinase A Synergistically Enhances Cytotoxicity in Ovarian Clear Cell Carcinoma Cell Lines Induced by Cisplatin: A Potential Treatment Strategy.2017
- Author(s)
  Chiba Y, Sato S, Itamochi H, Yoshino N, Fukagawa D, Kawamura H, Suga Y, Kojima-Chiba A, Muraki Y, Sugai T, Sugiyama T.
- Journal Title
  
  Int J Gynecol Cancer
  
  Volume: 8 Issue: 8 Pages: 1666-74
- DOI
  10.1097/igc.0000000000001081
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K11151, KAKENHI-PROJECT-17K08700
[Journal Article] Establishment and characterization of a novel uterine carcinosarcoma cell line, TU-ECS-1, with mutations of TP53 and KRAS.2017
- Author(s)
  Chiba Y, Sato S, Itamochi H, Suga Y, Fukagawa T, Oumi N, Oishi T, Harada T, Sugai T, Sugiyama T
- Journal Title
  
  Human Cell
  
  Volume: 30 Issue: 2 Pages: 140-148
- DOI
  10.1007/s13577-016-0154-6
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-16K11151
[Journal Article] Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.2015
- Author(s)
  Itamochi H, Oumi N, Oishi T, Shoji T, Fujiwara H, Sugiyama T, Suzuki M, Kigawa J, Harada T
- Journal Title
  
  Int J Clin Oncol
  
  Volume: 20 Issue: 5 Pages: 967-973
- DOI
  10.1007/s10147-015-0811-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25462594
[Journal Article] Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and nay be a novel therapeutic approach.2015
- Author(s)
  Itamochi H, Oumi N, Oishi T, Taniguchi F, Shoji T, Fujiwara H, Sugiyama T, Suzuki M, Kigawa J, Harada T.
- Journal Title
  
  Int J Gynecol Cancer
  
  Volume: 25 Issue: 4 Pages: 570-576
- DOI
  10.1097/igc.0000000000000414
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-24592517, KAKENHI-PROJECT-26462490
[Journal Article] Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.2015
- Author(s)
  Itamochi H, Oumi N, Oishi T, Shoji T, Fujiwara H, Sugiyama T, Suzuki M, Kigawa J, Harada T.
- Journal Title
  
  Int J Clin Oncol
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24592517
[Journal Article] The PI3K/mTOR dual Inhibitor NVP-BEZ235 Reduces Growth of Ovarian Clear Cell Carcinoma.2014
- Author(s)
  Oishi T, Itamochi H, Kudoh A, Nonaka M, Kato M, Nishimura M, Oumi N, Sato S, Naniwa J, Sato S, Shimada M, Kigawa J, Harada T.
- Journal Title
  
  Oncology Report
  
  Volume: 32
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25462594
[Journal Article] Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary.2014
- Author(s)
  Itamochi H, Nishimura M, Oumi N, Kato M, Oishi T, Shimada M, Sato S, Naniwa J, Sato S, Kudoh A, Kigawa J, Harada H.
- Journal Title
  
  Int J Gynecol Cancer
  
  Volume: 24 Issue: 1 Pages: 61-69
- DOI
  10.1097/igc.0000000000000014
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24592517
[Journal Article] Dual inhibition of phosphatidylinositol 3’-kinase and mammalian target of rapamycin using NVP-BEZ235 as a vovel therapeutic approach for mucinous adenocarcinoma of the ovary.2014
- Author(s)
  Kudoh A, Oishi T, Itamochi H, Sato S, Naniwa J, Sato S, Shimada M, Kigawa J, Harada T.
- Journal Title
  
  Int J Gynecol Cancer
  
  Volume: 24 Issue: 3 Pages: 444-453
- DOI
  10.1097/igc.0000000000000091
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24592517
[Journal Article] Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.2013
- Author(s)
  Itamochi H., Kato M., Nishimura M., Oumi N., Oishi T., Shimada M., Sato S., Naniwa J., Sato S., Nonaka M., Kudoh A., Terakawa N., Kigawa J., and Harada T.
- Journal Title
  
  Human Cell
  
  Volume: 26 Issue: 3 Pages: 121-127
- DOI
  10.1007/s13577-013-0062-y
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592517
[Journal Article] Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through upregulation of c-Jun2011
- Author(s)
  Itamochi H, Terakawa N, et al
- Journal Title
  
  Clin Cancer Res
  
  Volume: 17(14) Issue: 14 Pages: 4742-4750
- DOI
  10.1158/1078-0432.ccr-11-0190
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20249066
[Journal Article] Novel mechanism of reduced proliferation in ovarian clear carcinoma cells : cytoplasmic sequestration of CDK2 by p272011
- Author(s)
  Itamochi H, Terakawa N, et al
- Journal Title
  
  Gynecol Oncol
  
  Volume: 122(3) Issue: 3 Pages: 641-647
- DOI
  10.1016/j.ygyno.2011.05.003
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20249066
[Journal Article] Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cells induced by etoposide through upregulation of c-Jun2011
- Author(s)
  Itamochi H, Terakawa N, Harada T, et al.
- Journal Title
  
  Clin Cancer Res
  
  Volume: 17 Pages: 742-4750
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20249066
[Journal Article] Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells : Cytoplasmic sequestration of CDK2 by p272011
- Author(s)
  Itamochi H, Terakawa N, et al.
- Journal Title
  
  Gynecol Oncol
  
  Volume: 122 Pages: 641-647
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20249066
[Journal Article] Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma2008
- Author(s)
  Itamochi H, Terakawa N, et al.
- Journal Title
  
  Cancer Sci
  
  Volume: 99(4) Pages: 653-658
- NAID
  10024004412
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20249066
[Journal Article] 【婦人科関連抗がん剤の必修知識】8.ドキシル(塩酸ドキシルビシン)2008
- Author(s)
  板持広明
- Journal Title
  
  産科と婦人科 75
  
  Pages: 309-313
- Data Source
  KAKENHI-PROJECT-17591737
[Journal Article] Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma : a potential treatment strategy.2007
- Author(s)
  Itamochi H
- Journal Title
  
  Mol Cancer Ther. 6・1
  
  Pages: 227-235
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16591660
[Journal Article] 【研修医からの質問 Q&A】卵巣明細胞腺癌に推奨される化学療法は何でしょうか?2007
- Author(s)
  板持広明
- Journal Title
  
  臨床腫瘍プラクティス 3
  
  Pages: 438-438
- Data Source
  KAKENHI-PROJECT-17591737
[Journal Article] Adenovirus Type 5 EIA Gene Therapy for Ovarian Clear Cell Carcinoma : a Potential Treatment Strategy2007
- Author(s)
  Hiroaki Itamochi
- Journal Title
  
  Molecular Cancer Therapeutics 6
  
  Pages: 227-235
- Data Source
  KAKENHI-PROJECT-17591737
[Journal Article] A denovirus type 5 ElA gene therapy for ovarian clear cell carcinoma : a potential treatment strategy.2007
- Author(s)
  Itamochi H
- Journal Title
  
  Mol Cancer The r. 6・1
  
  Pages: 227-235
- Data Source
  KAKENHI-PROJECT-16591660
[Journal Article] Adenovirus Type 5 E1A Gene Therapy for Ovarian Clear Cell Carcinoma: a Potential Treatment Strategy2007
- Author(s)
  Hiroaki, Itamochi
- Journal Title
  
  Molecular Cancer Therapeutics 6
  
  Pages: 227-235
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Journal Article] Adenovirus Type 5 E1A Gene Therapy for Ovarian Clear Cell Carcinoma: a Potential Treatment Strategy.2007
- Author(s)
  Hiroaki Itamochi
- Journal Title
  
  Molecular Cancer Therapeutics 6
  
  Pages: 227-235
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17591737
[Journal Article] 上皮性卵巣癌における耐性遺伝子を用いた抗癌剤感受性試験2006
- Author(s)
  板持広明
- Journal Title
  
  日本婦人科腫瘍学会雑誌 24
  
  Pages: 21-25
- NAID
  10026152141
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Journal Article] Reduction of radiation-induced apoptosis by specific expression of Bcl-2 in normal cells.2006
- Author(s)
  Hiroaki Itamochi
- Journal Title
  
  Cancer Gene Therapy 13
  
  Pages: 451-459
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17591737
[Journal Article] Reduction of radiation-induced apoptosis by specific expression of Bc1-2 in normal cells2006
- Author(s)
  Hiroaki, Itamochi
- Journal Title
  
  Cancer Gene Therapy 13
  
  Pages: 451-459
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Journal Article] Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer2006
- Author(s)
  Hiroaki, Itamochi
- Journal Title
  
  Japanese Journal of Gynecological Oncology 24
  
  Pages: 21-25
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Journal Article] Reduction of radiation-induced apoptosis by specific expression of Bcl-2 in normal cells.
- Author(s)
  Hiroaki Itamochi
- Journal Title
  
  Cancer Gene Therapy (In press)
- Data Source
  KAKENHI-PROJECT-17591737
[Journal Article] Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma.
- Author(s)
  Hiroaki Itamochi
- Journal Title
  
  Cancer Science (in press)
- NAID
  10024004412
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17591737
[Journal Article] Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
- Author(s)
  Hiroaki, Itamochi
- Journal Title
  
  Cancer Sci (in press)
- NAID
  10024004412
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Journal Article] Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma.
- Author(s)
  Hiroaki Itamochi
- Journal Title
  
  Cancer Science (in press)
- NAID
  10024004412
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] Molecular and genetic alterations in ovarian clear cell carcinoma.2018
- Author(s)
  佐藤誠也, 板持広明.
- Organizer
  第60回日本婦人科腫瘍学会学術講演会
- Data Source
  KAKENHI-PROJECT-16K11151
[Presentation] 卵巣明細胞癌に対するAurora kinase A阻害剤を用いた至適併用化学療法の探索.2017
- Author(s)
  千葉洋平, 佐藤誠也, 板持広明, 杉山徹.
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-16K11151
[Presentation] Aurora-A inhibition synergistically enhances cisplatin induced cytotoxicity in ovarian clear cell carcinoma cell lines.2017
- Author(s)
  Chiba Y, Sato S, Fukagawa D, Suga Y, Kagabu M, Chiba A, Takeuchi S, Itamochi H, Sugai T, Sugiyama T.
- Organizer
  5th Biennial Meeting of Asian Society of Gynecologic Oncology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K11151
[Presentation] 卵巣明細胞腺癌におけるphosphatidylinositide 3-kinase (PI3K) - Akt経路およびARID1A蛋白発現と臨床的意義の検討2015
- Author(s)
  大石徹郎、板持広明、近江奈央、庄子忠宏、嵯峨泰、藤原寛行、島田宗昭、杉山徹、鈴木光明、紀川純三、原田省
- Organizer
  第67回日本産科婦人科学会学術講演会
- Place of Presentation
  神奈川県横浜市
- Year and Date
  2015-04-09
- Data Source
  KAKENHI-PROJECT-25462594
[Presentation] 卵巣明細胞腺癌におけるPI3K-Akt 経路およびARID1A 蛋白発現と臨床的意義の検討2015
- Author(s)
  大石徹郎、板持広明、庄子忠宏、嵯峨泰、藤原寛行、島田宗昭、杉山徹、鈴木光明、紀川純三、原田省
- Organizer
  第74回日本癌学会
- Place of Presentation
  愛知県名古屋市
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-25462594
[Presentation] Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach.2015
- Author(s)
  Itamochi H, Oumi N, Oishi T, Taniguchi F, Shoji T, Saga Y, Fujiwara H, Shimada M, Sugiyama T, Suzuki M, Kigawa J, Harada T.
- Organizer
  106th Annual Meeting of the American Association for Cancer Research
- Place of Presentation
  フィラデルフィア（アメリカ合衆国）
- Year and Date
  2015-04-21
- Data Source
  KAKENHI-PROJECT-24592517
[Presentation] 卵巣明細胞腺癌に対する線維芽細胞増殖因子受容体（FGFR）2シグナル伝達経路を標的とした新規治療戦略　難治性卵巣癌の克服を目指して.2014
- Author(s)
  板持広明
- Organizer
  第66回日本産科婦人科学会学術講演会シンポジウム
- Place of Presentation
  東京国際フォーラム（東京都）
- Year and Date
  2014-04-19
- Data Source
  KAKENHI-PROJECT-24592517
[Presentation] 卵巣癌癌性腹膜炎モデルに対するmTOR阻害剤を用いた至適併用化学療法の探索2011
- Author(s)
  板持広明、寺川直樹、原田省, 他
- Organizer
  第63回日本産科婦人科学会学術講演会
- Place of Presentation
  大阪国際会議場(大阪市)
- Year and Date
  2011-08-30
- Data Source
  KAKENHI-PROJECT-20249066
[Presentation] 卵巣癌に対するmTOR阻害剤を用いた至適併用化学療法の探索2011
- Author(s)
  板持広明、寺川直樹、原田省, 他
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場(名古屋市)
- Year and Date
  2011-10-03
- Data Source
  KAKENHI-PROJECT-20249066
[Presentation] 卵巣癌に対するmTOR阻害剤を用いた至適併用化学療法の探索2011
- Author(s)
  板持広明、寺川直樹、原田省, 他
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋市
- Year and Date
  2011-10-03
- Data Source
  KAKENHI-PROJECT-20249066
[Presentation] Inhibiting the mTOR pathway synergistically enhances etoposide-induced cytotoxicity by upregulating c-Jun in ovarian cancer cells2011
- Author(s)
  Itamochi H, Terakawa N, Harada T, et al.
- Organizer
  102th Annual Meeting of American Association for Cancer Reserach
- Place of Presentation
  Orlando, USA
- Year and Date
  2011-04-04
- Data Source
  KAKENHI-PROJECT-20249066
[Presentation] 卵巣癌癌性腹膜炎モデルに対するmTOR阻害剤を用いた至適併用化学療法の探索2011
- Author(s)
  板持広明、寺川直樹、原田省, 他
- Organizer
  第63回日本産科婦人科学会学術講演会
- Place of Presentation
  大阪市
- Year and Date
  2011-08-30
- Data Source
  KAKENHI-PROJECT-20249066
[Presentation] 卵巣明細胞腺癌に対するERKを標的とした分子標的治療2010
- Author(s)
  大石徹郎、板持広明、寺川直樹、原田省, 他
- Organizer
  第69回日本癌学会学術総会
- Place of Presentation
  名古屋市
- Year and Date
  2010-09-23
- Data Source
  KAKENHI-PROJECT-20249066
[Presentation] 卵巣明細胞腺癌に対するCDK2活性化によるCDDP耐性克服の試み2009
- Author(s)
  板持広明、寺川直樹, 他
- Organizer
  第61回日本産科婦人科学会学術講演会
- Place of Presentation
  京都市
- Year and Date
  2009-04-04
- Data Source
  KAKENHI-PROJECT-20249066
[Presentation] 卵巣明細胞腺癌における細胞増殖能と細胞内CDK2局剤の解析2008
- Author(s)
  板持広明、寺川直樹, 他
- Organizer
  第60回日本産科婦人科学会学術講演会
- Place of Presentation
  横浜市
- Year and Date
  2008-04-12
- Data Source
  KAKENHI-PROJECT-20249066
[Presentation] Novel treatment strategies for ovarian carcinoma.[Symposium]2007
- Author(s)
  Hiroaki, Itamochi
- Organizer
  43rd Annual Meeting of the Japan Society of Gynecologic Oncology
- Place of Presentation
  Yonago, Japan
- Year and Date
  2007-11-23
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] [シンポジウム]抗癌剤低感受性卵巣癌に対する治療戦略2007
- Author(s)
  板持広明
- Organizer
  第43回日本婦人科腫瘍学会
- Place of Presentation
  米子市
- Year and Date
  2007-11-23
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] 抗癌剤低感受性卵巣癌に対する治療戦略2007
- Author(s)
  板持広明
- Organizer
  第43回日本婦人科腫瘍学会学術集会
- Place of Presentation
  米子市
- Year and Date
  2007-11-23
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] 卵巣明細胞腺癌腹膜炎モデルに対するE1A遺伝子治療の試み2007
- Author(s)
  板持広明
- Organizer
  第59回日本産科婦人科学会
- Place of Presentation
  京都市
- Year and Date
  2007-04-17
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma2007
- Author(s)
  Hiroaki, Itamochi
- Organizer
  59th Annual Congress of the Japan Society of Obstetrics and Gynecology
- Place of Presentation
  Kyoto, Japan
- Year and Date
  2007-04-17
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma2006
- Author(s)
  Hiroaki, Itamochi
- Organizer
  97th Annual Meeting of American Association for Cancer Research
- Place of Presentation
  Washington D.C., USA
- Year and Date
  2006-04-05
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma A potential treatment strategy2006
- Author(s)
  Hiroaki, Itamochi
- Organizer
  11th Biennial Meeting International Gynecologic Cancer Society
- Place of Presentation
  Santa Monica, USA
- Year and Date
  2006-10-16
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma2006
- Author(s)
  Hiroaki, Itamochi
- Organizer
  58th Annual Congress of the Japan Society of Obstetrics and Gynecology
- Place of Presentation
  Yokohama, Japan
- Year and Date
  2006-04-24
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma.2006
- Author(s)
  Hiroaki Itamochi
- Organizer
  97th Annual Meeting of American Association for Cancer Research
- Place of Presentation
  Washington D. C.
- Year and Date
  2006-04-05
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma: A potential treatment strategy.2006
- Author(s)
  Hiroaki Itamochi
- Organizer
  11th Biennial Meeting International Gynecologic Cancer Society
- Place of Presentation
  Santa Monica
- Year and Date
  2006-10-16
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] 卵巣明細胞腺癌に対するE1A遺伝子治療の試み2006
- Author(s)
  板持広明
- Organizer
  第58回日本産科婦人科学会
- Place of Presentation
  横浜市
- Year and Date
  2006-04-24
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma2005
- Author(s)
  Hiroaki, Itamochi
- Organizer
  64th Annual Meeting of the Japan Cancer Association
- Place of Presentation
  Sapporo, Japan
- Year and Date
  2005-09-16
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] Novel mechanism reduces proliferation of clear cell carcinoma of the ovary:Cyclin-dependent kinase 2 (CDK2) activity is reduced by cytoplasmic sequestration of CDK2 by phosphorylated p272005
- Author(s)
  Hiroaki, Itamochi
- Organizer
  96th Annual Meeting of American Association for Cancer Research
- Place of Presentation
  Anaheim, USA
- Year and Date
  2005-04-20
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] Novel mechanism reduces proliferation of clear cell carcinoma of the ovary: Cyclin-dependent kinase 2 (CDK2) activity is reduced by cytoplasmic sequestration of CDK2 by phosphorylated p27.2005
- Author(s)
  Hiroaki Itamochi
- Organizer
  96th Annual Meeting of American Association for Cancer Research
- Place of Presentation
  Anaheim
- Year and Date
  2005-04-20
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] [シンポジウム]上皮性卵巣癌における耐性遺伝子を用いた抗癌剤感受性試験2005
- Author(s)
  板持広明
- Organizer
  第38回日本婦人科腫瘍学会
- Place of Presentation
  和歌山市
- Year and Date
  2005-07-22
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] Bcl-2 Antisense Oligonucleotide Overcomes Resistance to MA Gene Therapy in a Low HER2-Expressing Ovarian Cancer Xenograft Model2005
- Author(s)
  Hiroaki, Itamochi
- Organizer
  57th Annual Congress of the Japan Society of Obstetrics and Gynecology
- Place of Presentation
  Kyoto, Japan
- Year and Date
  2005-04-04
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer. [Symposium]2005
- Author(s)
  Hiroaki, Itamochi
- Organizer
  38th Annual Meeting of the Japan Society of Gynecologic Oncology
- Place of Presentation
  Kyoto, Japan
- Year and Date
  2005-07-22
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] 卵巣明細胞腺癌に対するE1A遺伝子治療の試み2005
- Author(s)
  板持広明
- Organizer
  第64回日本癌学会
- Place of Presentation
  札幌市
- Year and Date
  2005-09-16
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] 上皮性卵巣癌におけるアンチセンスBcl-2を用いたE1A遺伝子治療耐性克服の試み2005
- Author(s)
  板持広明
- Organizer
  第57回日本産科婦人科学会
- Place of Presentation
  京都市
- Year and Date
  2005-04-04
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] 卵巣明細胞腺癌に対する線維芽細胞増殖因子受容体（FGFR）2 シグナル伝達経路を標的とした新規治療戦略
- Author(s)
  板持広明
- Organizer
  日本産科婦人科学会学術講演会　シンポジウム
- Place of Presentation
  東京国際フォーラム
- Data Source
  KAKENHI-PROJECT-24592517

1. KIGAWA Junzo (00177784)

# of Collaborated Projects: 5 results

# of Collaborated Products: 10 results
2. TERAKAWA Naoki (90163906)

# of Collaborated Projects: 4 results

# of Collaborated Products: 13 results
3. SATO Seiya (30621007)

# of Collaborated Projects: 4 results

# of Collaborated Products: 9 results
4. 利部正裕 (30382609)

# of Collaborated Projects: 4 results

# of Collaborated Products: 2 results
5. SATO Syinya (10423261)

# of Collaborated Projects: 3 results

# of Collaborated Products: 4 results
6. HARADA Tasuku (40218649)

# of Collaborated Projects: 3 results

# of Collaborated Products: 17 results
7. SHIMADA Muneaki (40362892)

# of Collaborated Projects: 3 results

# of Collaborated Products: 7 results
8. OISHI Tetsuro (80359877)

# of Collaborated Projects: 3 results

# of Collaborated Products: 10 results
9. KANAMORI Yasunobu (70283984)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
10. 馬場長 (60508240)

# of Collaborated Projects: 3 results

# of Collaborated Products: 1 results
11. CHIKUMI Jun (70467702)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
12. 小島淳美 (60508753)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
13. 庄子忠宏 (00337148)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
14. TANIGUCHI Fuminori (40322218)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. HAYASHI Kunihiko (80282408)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. KOBAYASHI Hiroshi (40178330)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. MOMOEDA Mikio (50221627)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
18. 高橋正国 (30379622)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
19. 小見英夫 (20382608)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
20. 杉山徹 (40162903)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
21. 竹内聡 (60252772)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
22. 永沢崇幸 (10453309)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
23. 苫米地英俊 (10771363)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
24. 深川安寿子 (30772511)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
25. 岩谷岳 (70405801)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
26. 遠藤史隆 (70714442)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
27. 千葉洋平 (20892847)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
28. NANIWA Jun

# of Collaborated Projects: 0 results

# of Collaborated Products: 4 results

Itamochi Hiroaki 板持 広明

ITAMOCHI Hiroaki 板持 広明

Research Projects

Research Products

Co-Researchers

卵巣明細胞癌に対するＨＳＦ１経路を標的とした新規治療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

子宮癌肉腫に対する免疫逃避改善を誘導するウイルス療法の開発

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The NEFH pathway may be a novel therapeutic target for ovarian clear cell carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The KANK1 pathway may be a novel therapeutic target for ovarian clear cell carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of combination therapy using PI3K inhibitor and its predictive biomarker in clear cell carcinoma of the ovary

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approachPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Investigation into malignant transformation of endometriosis. prospective cohort study and molecular biology research

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Adenovirus type 5 EIA gene therapy for ovarian carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Order made gene therapy for epithelial ovarian cancer on biological behavior

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

卵巣明細胞腺癌の抗癌剤耐性機序とその克服Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Gene therapy enhances chemotherapy induced apoptosis in a peritonitis carcinomatosa model with ovarian cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] よくわかる卵巣癌のすべて2007

Author(s)

Publisher

Description

Data Source

[Book] All about ovarian carcinoma2007

Author(s)

Publisher

Description

Itamochi Hiroaki 板持広明

ITAMOCHI Hiroaki 板持広明